Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 14, 2013 - Issue 9
Submit an article Journal homepage
1,175
Views
43
CrossRef citations to date
0
Altmetric
Reviews

Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials

Luis MáizRamón y Cajal University Hospital, Unit of Bronchiestasis and Cystic Fibrosis, Respiratory Department, Madrid, [email protected]
,
Rosa M GirónLa Princesa University Hospital, Unit of Bronchiestasis and Cystic Fibrosis (Coordinator), Biomedical Research Foundation, Madrid, Spain
,
Casilda OlveiraCarlos Haya Regional University Hospital, Unit of Cystic Fibrosis and Bronchiestasis, Respiratory Department, Málaga, Spain
,
Esther QuintanaVirgen del Rocío University Hospital, Unit of Cystic Fibrosis, Respiratory Department, Sevilla, Spain
,
Adelaida LamasRamón y Cajal University Hospital, Unit of Bronchiestasis and Cystic Fibrosis, Respiratory Department, Madrid, [email protected]
,
Dolores PastorVirgen de la Arrixaca University Hospital, Unit of Pediatric Pulmonology and Cystic Fibrosis, El Palmar, Spain
,
Rafael CantónRamón y Cajal University Hospital, Department of Microbiology, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
&
Josep MensaHospital Clinic, Department of Infectious Diseases, Barcelona, Spain
 show all
Pages 1135-1149 | Published online: 16 Apr 2013

Citations (43)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

E. Vazquez-Espinosa, C. Marcos, T. Alonso, R.M. Giron, R.M. Gomez-Punter, E. Garcia-Castillo, E. Zamora, C. Cisneros, J. Garcia, C. Valenzuela & J. Ancochea. (2016) Tobramycin inhalation powder (TOBI Podhaler®) for the treatment of lung infection in patients with cystic fibrosis. Expert Review of Anti-infective Therapy 14:1, pages 9-17.
Read now
Charlotte Addy, Damian G Downey & J Stuart Elborn. (2016) Improvements in symptomatic treatment strategies for cystic fibrosis: delivering CF care in the 21st century. Expert Opinion on Orphan Drugs 4:1, pages 5-19.
Read now
Emma Vázquez-Espinosa, Rosa María Girón, Rosa Mar Gómez-Punter, Elena García-Castillo, Claudia Valenzuela, Carolina Cisneros, Enrique Zamora, F Javier García-Pérez & Julio Ancochea. (2015) Long-term safety and efficacy of tobramycin in the management of cystic fibrosis. Therapeutics and Clinical Risk Management 11, pages 407-415.
Read now
Zarmina Ehsan & John Clancy. (2015) T100: nebulized-concentrated tobramycin formulation for treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients. Expert Opinion on Orphan Drugs 3:8, pages 933-943.
Read now
José Luis Justicia, Amparo Solé, Esther Quintana-Gallego, Silvia Gartner, Javier de Gracia, Concepción Prados & Luis Máiz. (2015) Management of pulmonary exacerbations in cystic fibrosis: still an unmet medical need in clinical practice. Expert Review of Respiratory Medicine 9:2, pages 183-194.
Read now
Cordula Koerner-Rettberg & Manfred Ballmann. (2014) Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy. Core Evidence 9, pages 99-112.
Read now

Articles from other publishers (37)

Christine Esposito, Martin Kamper, Jessica Trentacoste, Susan Galvin, Halie Pfister & Janice Wang. (2023) Advances in the Cystic Fibrosis Drug Development Pipeline. Life 13:9, pages 1835.
Crossref
Moamen M. Elmassry, Jane A. Colmer-Hamood, Jonathan Kopel, Michael J. San Francisco & Abdul N. Hamood. (2023) Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials. Microorganisms 11:4, pages 916.
Crossref
Orsolya Varannai, Noémi Gede, Márk Félix Juhász, Zsolt Szakács, Fanni Dembrovszky, Dávid Németh, Péter Hegyi & Andrea Párniczky. (2021) Therapeutic Approach of Chronic Pseudomonas Infection in Cystic Fibrosis—A Network Meta-Analysis. Antibiotics 10:8, pages 936.
Crossref
Camille Jutras, Julie Autmizguine, Maryline Chomton, Christopher Marquis, The Thanh-Diem Nguyen, Nadia Roumeliotis & Guillaume Emeriaud. (2021) Inhaled Antibiotics for the Prevention of Respiratory Tract Infections in Children With a Tracheostomy. Frontiers in Pediatrics 9.
Crossref
Marta Garcia-Clemente, David de la Rosa, Luis Máiz, Rosa Girón, Marina Blanco, Casilda Olveira, Rafael Canton & Miguel Angel Martinez-García. (2020) Impact of Pseudomonas aeruginosa Infection on Patients with Chronic Inflammatory Airway Diseases. Journal of Clinical Medicine 9:12, pages 3800.
Crossref
David de la Rosa Carrillo, José Luís López-Campos, Bernardino Alcázar Navarrete, Myriam Calle Rubio, Rafael Cantón Moreno, Juan Luis García-Rivero, Luís Máiz Carro, Casilda Olveira Fuster, Miguel Ángel Martínez-García, Francisco Javier Callejas, Ángela Cervera Juan, Marta Palop Cervera, Antonia Fuster Gomila, Alicia Marín Tapia, Xavier Pomares Amigo, Mirian Torres González, Jacinto Hernández Borge, Gerardo Pérez Chica, Rocío Jimeno Galván, Rafael Golpe Gómez, Pedro J. Marcos Rodríguez, Pilar Cebollero Rivas, Eva Tabernero Huguet, Carlos Álvarez Martínez, Concha Prados Sánchez, José Javier Martínez Garcerán, Carlos Peñalver Mellado, Marta García Clemente, Juan Rodríguez López, Juan Marco Figueira Gonçalves, Guillermo José Pérez Mendoza, Jesús Hernández Hernández, Carlos Amado Diago, Laura Pérez Giménez, Virginia Moya Álvarez, Alexandre Palou Rotger, Rosa Girón Moreno, Marina Blanco Aparicio, Annie Navarro Rolón, Oriol Sibila, Marc Miravitlles Fernández, Juan José Soler Cataluña, José Alberto Fernández Villar & Germán Peces-Barba Romero. (2020) Documento de consenso sobre el diagnóstico y tratamiento de la infección bronquial crónica en la enfermedad pulmonar obstructiva crónica. Archivos de Bronconeumología 56:10, pages 651-664.
Crossref
David de la Rosa Carrillo, José Luís López-Campos, Bernardino Alcázar Navarrete, Myriam Calle Rubio, Rafael Cantón Moreno, Juan Luis García-Rivero, Luís Máiz Carro, Casilda Olveira Fuster & Miguel Ángel Martínez-García. (2020) Consensus document on the diagnosis and treatment of chronic bronchial infection in chronic obstructive pulmonary disease. Archivos de Bronconeumología (English Edition) 56:10, pages 651-664.
Crossref
Zhan-Juan Zhao, Zeng-Ping Xu, Ying-Ying Ma, Jin-Duo Ma & Ge Hong. (2020) Photodynamic antimicrobial chemotherapy in mice with Pseudomonas aeruginosa-infected wounds. PLOS ONE 15:9, pages e0237851.
Crossref
José Luis Lopez-Campos, Marc Miravitlles, David de la Rosa Carrillo, Rafael Cantón, Juan Jose Soler-Cataluña & Miguel Angel Martinez-Garcia. (2020) Current Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine 9:6, pages 1639.
Crossref
Concepción Prados, Ester Zamarrón, Rosa Girón, Esther Quintana, Luis Máiz, Rosa Nieto, Óscar Asensio, Rodolfo Álvarez-Sala, Sarai Quirós, María Martínez-Redondo, Alberto Mangas & Teresa Martínez-Martínez. (2020) ¿Qué supuso el consenso español para el tratamiento de la infección por Pseudomonas aeruginosa en pacientes con fibrosis quística en la infección pulmonar inicial?. Medicina Clínica 154:6, pages 232-235.
Crossref
Concepción Prados, Ester Zamarrón & Rosa Girón. (2020) What Spanish consensus meant for the treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis in the initial lung infection?. Medicina Clínica (English Edition) 154:6, pages 232-235.
Crossref
Jaime Lora-Tamayo, Oscar Murillo & Javier Ariza. 2019. Polymyxin Antibiotics: From Laboratory Bench to Bedside. Polymyxin Antibiotics: From Laboratory Bench to Bedside 181 195 .
Hanzey Yasar, Duy-Khiet Ho, Chiara De Rossi, Jennifer Herrmann, Sarah Gordon, Brigitta Loretz & Claus-Michael Lehr. (2018) Starch-Chitosan Polyplexes: A Versatile Carrier System for Anti-Infectives and Gene Delivery. Polymers 10:3, pages 252.
Crossref
Semanur Kuyucu & Tugba Arıkoglu. (2018) How to Manage Antibiotic Allergy in Cystic Fibrosis? Epidemiologic, Diagnostic, and Therapeutic Aspects. Current Treatment Options in Allergy 5:1, pages 74-102.
Crossref
Jasmim Leal, Hugh D.C. Smyth & Debadyuti Ghosh. (2017) Physicochemical properties of mucus and their impact on transmucosal drug delivery. International Journal of Pharmaceutics 532:1, pages 555-572.
Crossref
Felix C. Ringshausen, James D. Chalmers & Mathias W. Pletz. 2017. Anti-infectives and the Lung. Anti-infectives and the Lung 57 79 .
Danielle M. Goetz & Shipra Singh. (2016) Respiratory System Disease. Pediatric Clinics of North America 63:4, pages 637-659.
Crossref
Mark P. Murphy & Emma Caraher. (2016) Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its Symptoms. Drugs in R&D 16:1, pages 1-17.
Crossref
Winston Ong, Pawel Nowak, Yen Cu, Lisa Schopf, James Bourassa, Elizabeth Enlow, Samuel M. Moskowitz & Hongming Chen. (2015) Sustained Pulmonary Delivery of a Water-Soluble Antibiotic Without Encapsulating Carriers. Pharmaceutical Research 33:3, pages 563-572.
Crossref
Andreia P. Magalhães, Nuno F. Azevedo, Maria O. Pereira & Susana P. Lopes. (2015) The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy. Applied Microbiology and Biotechnology 100:3, pages 1163-1181.
Crossref
Zarmina Ehsan & John P Clancy. (2015) Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin . Future Microbiology 10:12, pages 1901-1912.
Crossref
Jessica E. Pittman & Thomas W. Ferkol. (2015) The Evolution of Cystic Fibrosis Care. Chest 148:2, pages 533-542.
Crossref
Arianna Pompilio, Valentina Crocetta, Stefano Pomponio, Ersilia Fiscarelli & Giovanni Di Bonaventura. (2015) In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under “cystic fibrosis–like” physicochemical conditions. Diagnostic Microbiology and Infectious Disease 82:4, pages 318-325.
Crossref
Aukje C. Bos, Cedric van Holsbeke, Jan W. de Backer, Mireille van Westreenen, Hettie M. Janssens, Wim G. Vos & Harm A. W. M. Tiddens. (2015) Patient-Specific Modeling of Regional Antibiotic Concentration Levels in Airways of Patients with Cystic Fibrosis: Are We Dosing High Enough?. PLOS ONE 10:3, pages e0118454.
Crossref
Katy McAllister & James D. Chalmers. (2015) Old Drugs for Bad Bugs—Aerosolized Antibiotics in Ventilator-Associated Pneumonia*. Critical Care Medicine 43:3, pages 697-698.
Crossref
Rafael Cantón, Luis Máiz, Amparo Escribano, Casilda Olveira, Antonio Oliver, Oscar Asensio, Silvia Gartner, Eva Roma, Esther Quintana-Gallego, Antonio Salcedo, Rosa Girón, María Isabel Barrio, María Dolores Pastor, Concepción Prados, María Teresa Martínez-Martínez, José Barberán, Juan José Castón, Luis Martínez-Martínez, José Luis Poveda, Carlos Vázquez, Javier de Gracia & Amparo Solé. (2015) Consenso español para la prevención y el tratamiento de la infección bronquial por Pseudomonas aeruginosa en el paciente con fibrosis quística. Archivos de Bronconeumología 51:3, pages 140-150.
Crossref
Rafael Cantón, Luis Máiz, Amparo Escribano, Casilda Olveira, Antonio Oliver, Oscar Asensio, Silvia Gartner, Eva Roma, Esther Quintana-Gallego, Antonio Salcedo, Rosa Girón, María Isabel Barrio, María Dolores Pastor, Concepción Prados, María Teresa Martínez-Martínez, José Barberán, Juan José Castón, Luis Martínez-Martínez, José Luis Poveda, Carlos Vázquez, Javier de Gracia & Amparo Solé. (2015) Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients. Archivos de Bronconeumología (English Edition) 51:3, pages 140-150.
Crossref
Eanna Forde & Marc Devocelle. (2015) Pro-Moieties of Antimicrobial Peptide Prodrugs. Molecules 20:1, pages 1210-1227.
Crossref
Casilda Olveira, Ana Muñoz & Adolfo Domenech. (2014) Terapia nebulizada. Año SEPAR. Archivos de Bronconeumología 50:12, pages 535-545.
Crossref
Casilda Olveira, Ana Muñoz & Adolfo Domenech. (2014) Nebulized Therapy. SEPAR Year. Archivos de Bronconeumología (English Edition) 50:12, pages 535-545.
Crossref
Susan HoeMohammed A. BoraeyJames W. IveyWarren H. FinlayReinhard Vehring. (2014) Manufacturing and Device Options for the Delivery of Biotherapeutics. Journal of Aerosol Medicine and Pulmonary Drug Delivery 27:5, pages 315-328.
Crossref
David Cipolla, Boris Shekunov, Jim Blanchard & Anthony Hickey. (2014) Lipid-based carriers for pulmonary products: Preclinical development and case studies in humans. Advanced Drug Delivery Reviews 75, pages 53-80.
Crossref
L. Kurzidim, C. Schwarz, N. Schönfeld, T.T. Bauer & M. Barker. (2014) Non-CF-Bronchiektasie im Kindes- und ErwachsenenalterNon-cystic fibrosis bronchiectasis in children and adults. Der Pneumologe 11:2, pages 110-119.
Crossref
Éanna Forde, Hilary Humphreys, Catherine M. Greene, Deirdre Fitzgerald-Hughes & Marc Devocelle. (2014) Potential of Host Defense Peptide Prodrugs as Neutrophil Elastase-Dependent Anti-Infective Agents for Cystic Fibrosis. Antimicrobial Agents and Chemotherapy 58:2, pages 978-985.
Crossref
A. Iglesias, I. Artiles, J. J. Cabanillas, R. Álvarez-Sala & C. Prados. (2014) Eradication of Burkholderia cepacia Using Inhaled Aztreonam Lysine in Two Patients with Bronchiectasis . Case Reports in Pulmonology 2014, pages 1-3.
Crossref
Justin Jackson, Caroline Chen & Kirsty Buising. (2013) Aminoglycosides. Current Opinion in Infectious Diseases 26:6, pages 516-525.
Crossref
Rashmi Ranjan Das, Sushil Kumar Kabra & Meenu Singh. (2013) Treatment of Pseudomonas and Staphylococcus Bronchopulmonary Infection in Patients with Cystic Fibrosis . The Scientific World Journal 2013, pages 1-13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.